DRREDDY - Dr Reddy's Laboratories Ltd - Longterm - Bullish
1. Annual Revenue rose 16.78%, in the last year to Rs 25,725 Crores. Its sector's average revenue growth for the last fiscal year was 8.64%.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
2. Annual Net Profit rose 106.52% in the last year to Rs 4,507 Crores. Its sector's average net profit growth for the last fiscal year was 2.34%.
3. Debt to Equity Ratio of 0.05 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
4. Interest Coverage Ratio is 51.85, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
5. Price to Earning Ratio is 19.19, lower than its sector PE ratio of 43.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。